Deciphera initiated with an Outperform at Raymond James
Raymond James analyst Laura Chico initiated Deciphera with an Outperform and $47 price target saying it is an intriguing kinase inhibitor platform play, with wholly-owned assets and a unique inhibitor design strategy.https://bit.ly/2POzkRR
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.